Generics For Risperdal Consta Need Multi-Dose Testing, J&J Argues
This article was originally published in The Pink Sheet Daily
Executive Summary
Citizen petition tells FDA not to worry about bioequivalence tests in fasting patients, but focus on the product's three-stage release characteristics.